2022
DOI: 10.25082/ccr.2022.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Women’s breast cancer risk factors in Kinshasa, Democratic Republic of the Congo

Abstract: Purpose: Breast cancer (BC) is the most common malignancy and the leading cause of cancer-related deaths among women worldwide. Risk factors for this disease are numerous and their prevalence varies according to racial and ethnic groups and geographical regions. Therefore, we sought to identify BC risk factors in the Congolese population. Methods: A case-control study was conducted at the Nganda Hospital Center in Kinshasa, Democratic Republic of the Congo. One hundred and sixty patients with breast cancer (ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…Zeng et al attempted the potentials of Pinus massoniana bark extract (PMBE), a Chinese natural product, on fighting against cancer via inducing the senescence of human hepatoma HepG2 cells in vitro [8]. Mukuku's team reported their series of research results on malignant tumors of Congo local characteristics [9][10][11][12]. Langer et al displayed their critical thinking about hematogone hyperplasia [13] and novel careful observation on Day 21 serum FLC level variation during therapy of symptomatic multiple myeloma [14].…”
mentioning
confidence: 99%
“…Zeng et al attempted the potentials of Pinus massoniana bark extract (PMBE), a Chinese natural product, on fighting against cancer via inducing the senescence of human hepatoma HepG2 cells in vitro [8]. Mukuku's team reported their series of research results on malignant tumors of Congo local characteristics [9][10][11][12]. Langer et al displayed their critical thinking about hematogone hyperplasia [13] and novel careful observation on Day 21 serum FLC level variation during therapy of symptomatic multiple myeloma [14].…”
mentioning
confidence: 99%